These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 32406337)

  • 1. Revealing the interaction modes of 5-HT2A receptor antagonists and the Structure-Based virtual screening from FDA and TCMNP database.
    Wang Y; Joseph J; Gao Y; Hu B; Geng X; Wu D; Wang J; Zhang F
    J Biomol Struct Dyn; 2021 Jul; 39(10):3681-3692. PubMed ID: 32406337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of novel dopamine D
    Zhang C; Li Q; Meng L; Ren Y
    J Biomol Struct Dyn; 2020 Feb; 38(3):860-885. PubMed ID: 30916624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel identification approach for discovery of 5-HydroxyTriptamine 2A antagonists: combination of 2D/3D similarity screening, molecular docking and molecular dynamics.
    Kumar R; Jade D; Gupta D
    J Biomol Struct Dyn; 2019 Mar; 37(4):931-943. PubMed ID: 29468945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular modeling and docking study on dopamine D2-like and serotonin 5-HT2A receptors.
    Duan X; Zhang M; Zhang X; Wang F; Lei M
    J Mol Graph Model; 2015 Apr; 57():143-55. PubMed ID: 25728902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism Exploration of Arylpiperazine Derivatives Targeting the 5-HT
    Lin F; Li F; Wang C; Wang J; Yang Y; Yang L; Li Y
    Molecules; 2017 Jun; 22(7):. PubMed ID: 28672848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refined pharmacophore features for virtual screening of human thromboxane A2 receptor antagonists.
    Hu B; Joseph J; Geng X; Wu Y; Suleiman MR; Liu X; Shi J; Wang X; He Z; Wang J; Cheng M
    Comput Biol Chem; 2020 Jun; 86():107249. PubMed ID: 32199335
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Radan M; Ruzic D; Antonijevic M; Djikic T; Nikolic K
    J Biomol Struct Dyn; 2021 Mar; 39(5):1819-1837. PubMed ID: 32141385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular modelling of human 5-hydroxytryptamine receptor (5-HT2A) and virtual screening studies towards the identification of agonist and antagonist molecules.
    Gandhimathi A; Sowdhamini R
    J Biomol Struct Dyn; 2016 May; 34(5):952-70. PubMed ID: 26327576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel tumor necrosis factor-α (TNF-α) inhibitors from small molecule library screening for their therapeutic activity profiles against rheumatoid arthritis using target-driven approaches and binary QSAR models.
    Zaka M; Abbasi BH; Durdagi S
    J Biomol Struct Dyn; 2019 Jun; 37(9):2464-2476. PubMed ID: 30047845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of new chemotypes of dual 5-HT
    Radan M; Djikic T; Nikolic K
    Future Med Chem; 2022 Jul; 14(13):963-989. PubMed ID: 35674007
    [No Abstract]   [Full Text] [Related]  

  • 11. Identification of HDAC6 selective inhibitors: pharmacophore based virtual screening, molecular docking and molecular dynamics simulation.
    Yan G; Li D; Zhong X; Liu G; Wang X; Lu Y; Qin F; Guo Y; Duan S; Li D
    J Biomol Struct Dyn; 2021 Apr; 39(6):1928-1939. PubMed ID: 32178584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of novel G-protein-coupled receptor 40 (GPR40) agonists by hybrid
    Nath V; Ahuja R; Kumar V
    J Biomol Struct Dyn; 2019 Sep; 37(14):3764-3787. PubMed ID: 30252605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacophore modeling, multiple docking, and molecular dynamics studies on Wee1 kinase inhibitors.
    Hu Y; Zhou L; Zhu X; Dai D; Bao Y; Qiu Y
    J Biomol Struct Dyn; 2019 Jul; 37(10):2703-2715. PubMed ID: 30052133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of selective MMP-9 inhibitors through multiple e-pharmacophore, ligand-based pharmacophore, molecular docking, and density functional theory approaches.
    Jana S; Singh SK
    J Biomol Struct Dyn; 2019 Mar; 37(4):944-965. PubMed ID: 29475408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined pharmacophore modeling, 3D-QSAR and docking studies to identify novel HDAC inhibitors using drug repurposing.
    Liu J; Zhu Y; He Y; Zhu H; Gao Y; Li Z; Zhu J; Sun X; Fang F; Wen H; Li W
    J Biomol Struct Dyn; 2020 Feb; 38(2):533-547. PubMed ID: 30938574
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Tran TT; Tran QH; Duong CQ; Nguyen QT; Tran VT; Le MT; Tran VH; Thai KM
    J Biomol Struct Dyn; 2023; 41(22):13154-13167. PubMed ID: 36709441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery and in vitro Evaluation of Novel Serotonin 5-HT
    Zięba A; Bartuzi D; Stępnicki P; Matosiuk D; Wróbel TM; Laitinen T; Castro M; Kaczor AA
    ChemMedChem; 2024 Jul; 19(14):e202400080. PubMed ID: 38619283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug repositioning to propose alternative modulators for glucocorticoid receptor through structure-based virtual screening.
    Metin R; Akten ED
    J Biomol Struct Dyn; 2022; 40(21):11418-11433. PubMed ID: 34355665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural Investigation of Vinca Domain Tubulin Binders by Pharmacophore, Atom based QSAR, Docking and Molecular Dynamics Simulations.
    Athar M; Lone MY; Khedkar VM; Radadiya A; Shah A; Jha PC
    Comb Chem High Throughput Screen; 2017; 20(8):682-695. PubMed ID: 28486912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homology modeling, molecular dynamics and virtual screening of endothelin-A receptor for the treatment of pulmonary arterial hypertension.
    Gu X; Wang Y; Wang H; Wu H; Li W; Wang J; Li N
    J Biomol Struct Dyn; 2021 Jul; 39(11):3912-3923. PubMed ID: 32431219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.